Blog
RSS FeedPosted by Michael Wonder on 07 May 2017
Funding for insomnia drug praised by parents, as PHARMAC gets $60m boost
7 May 2017 - The family of an autistic five-year-old who used to sleep just three hours a night is ...
Posted by Michael Wonder on 07 May 2017
Redistribution and redesign in health care: an ebbing tide in England versus growing concerns in the United States
4 May 2017 - Like many countries, the health care industries of England and the United States consume large amounts ...
Posted by Michael Wonder on 07 May 2017
New NICE criteria for drug access
1 May 2017 - An overhaul of NHS drug access in England by NICE and NHS England, which for the first ...
Posted by Michael Wonder on 06 May 2017
NICE rejects Orexigen’s weight-loss pill
5 May 2017 - The National Institute for Health and Care Excellence has published draft guidelines turning down Orexigen’s weight ...
Posted by Michael Wonder on 05 May 2017
Engaging specialist oncologists in the assessment of oncology drugs in Canada
1 May 2017 - The assessment of new cancer drugs in Canada increasingly engages specialist oncology physicians. This has not always ...
Posted by Michael Wonder on 04 May 2017
Medicines in New Zealand are overlooked and underfunded
4 May 2017 - Medicines New Zealand today released their latest Annual Report, The New Zealand Medicines Landscape 2016. It ...
Posted by Michael Wonder on 04 May 2017
Pfizer to give out breast cancer drug free while awaiting NHS decision
4 May 2017 - Pharmaceutical firm says it will offer palbociclib to patients while regulator rules on whether it should be ...
Posted by Michael Wonder on 04 May 2017
High-income earners could be in Medicare firing line
4 May 2017 - High-income earners could be hit with higher taxes through the health system to help the Turnbull ...
Posted by Michael Wonder on 04 May 2017
Private health insurance premiums set to get cheaper across Australia
4 May 2017 - Private health insurance premiums could be $150 lower from next year after the Federal Government moved ...
Posted by Michael Wonder on 04 May 2017
Another small victory for Australian Government in its pursuit of damages for PBS over-payments during interlocutory injunction period
4 May 2017 - The Australian Government has had another small victory in the most recent interlocutory decision in the clopidogrel ...
Posted by Michael Wonder on 04 May 2017
Metoprolol shortage ends but pharmacists remain concerned
4 May 2017 - Pharmacists are relieved the long-running shortage of heart medication metoprolol succinate is over, but are concerned ...
Posted by Michael Wonder on 03 May 2017
NICE recommends Janssen's first-of-its-kind Crohn's drug Stelara
3 May 2017 - Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the indication ...
Posted by Michael Wonder on 03 May 2017
Law finally passed to ban medicine price hiking by greedy drug firms
3 May 2017 - New legislation which is set to ban greedy drugs firms from extracting hundreds of millions of ...
Posted by Michael Wonder on 03 May 2017
International harmonisation of ingredient names – PBS changes
3 May 2017 - Some active ingredient names used in Australia differ from those used internationally. ...
Posted by Michael Wonder on 02 May 2017
'Stop stripping PHARMAC of its money' - Campaigner's message to Government
2 May 2017 - PHARMAC is not likely to fund medication for rare diseases anytime soon. ...